In Vitro Activity of Trovafloxacin Compared to Those of Five Antimicrobials against Mycoplasmas Including Mycoplasma hominis and Ureaplasma urealyticum Fluoroquinolone-Resistant Isolates That Have Been Genetically Characterized
- 1 September 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (9) , 2557-2560
- https://doi.org/10.1128/aac.44.9.2557-2560.2000
Abstract
The in vitro activity of trovafloxacin against 125 strains ofMycoplasma species and Ureaplasma urealyticum, including fluoroquinolone-susceptible and fluoroquinolone-resistant species, was compared to those of other fluoroquinolones, doxycycline, and erythromycin. The MIC at which 90% of isolates are inhibited for all fluoroquinolone-susceptible strains was 0.25 μg/ml. Whatever the associated mutations, trovafloxacin exhibited greater activity than the other fluoroquinolones tested against fluoroquinolone-resistantMycoplasma hominis and U. urealyticum isolates.Keywords
This publication has 11 references indexed in Scilit:
- In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.Journal of Antimicrobial Chemotherapy, 1999
- Mutations in the gyrA , parC , and parE Genes Associated with Fluoroquinolone Resistance in Clinical Isolates of Mycoplasma hominisAntimicrobial Agents and Chemotherapy, 1999
- Alterations in Topoisomerase IV and DNA Gyrase in Quinolone-Resistant Mutants of Mycoplasma hominis Obtained In VitroAntimicrobial Agents and Chemotherapy, 1998
- Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase ResistanceClinical Infectious Diseases, 1998
- In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against MycoplasmasAntimicrobial Agents and Chemotherapy, 1998
- In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolatesJournal of Antimicrobial Chemotherapy, 1997
- Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1997
- Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)Antimicrobial Agents and Chemotherapy, 1996
- Determination of minimal inhibitory concentrationPublished by Elsevier ,1996
- In vitro activity of the new fluoroquinolone CP-99,219Antimicrobial Agents and Chemotherapy, 1994